Spero Therapeutics
SPRO
#9538
Rank
C$77.05 M
Marketcap
$1.41
Share price
-2.00%
Change (1 day)
-27.65%
Change (1 year)

Spero Therapeutics (SPRO) Fails to deliver data

Key failure to deliver metrics for Spero Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Spero Therapeutics (SPRO) - 3 months history

Number of shares, 3 months chart

Oct 2024Nov 202420K40K60K80K100K0.12M0companiesmarketcap.com

Biweekly Failures to deliver volume for Spero Therapeutics (SPRO) - since 2017

Volume in USD (price x number of shares), data since 2017 2018201920202021202220232024$1M$2M$3M$4M0companiesmarketcap.com

Spero Therapeutics (SPRO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024C$0.46 M-46.01%
2023C$0.85 M-88.65%
2022C$7.55 M81.02%
2021C$4.17 M23.57%
2020C$3.37 M2331.08%
2019C$0.13 M-93.38%
2018C$2.09 M-76.81%
2017C$9.04 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
C$1.54 MC$1.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$88.29 MC$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$15.02 MC$0.17 B๐Ÿ‡จ๐Ÿ‡ฆ Canada